Type 2 diabetes mellitus in Bangladesh: a prevalence based cost-of-illness study

Table 4 Median regression analysis of total cost

Variables	Unadjusted			Adjusted
Variables	Coefficients	p-value	95% confidence interval (CI)	Coefficients	p-value	95% confidence interval (CI)
Gender (ref: Male)
Female	19.03	0.492	−35.32-73.37	44.85	0.036	3.02–86.68
Age (≤40 years)
41–60 years	82.85	0.107	−17.79-183.49	21.13	0.419	−30.13-72.39
61–80 years	221.91	< 0.001	113.60–330.24	2.86	0.930	−60.70-66.41
≥ 80 years	741.58	< 0.001	499.87–938.30	170.76	0.708	− 723.11-1064.64
Mode of treatment (ref: OHA)
Insulin	140.69	0.042	5.28–276.09	65.40	0.260	−48.28-179.07
Insulin + OHA	307.38	< 0.001	237.90–377.65	152.87	< 0.001	107.45–198.30
Duration of diabetes (ref: ≤5 year)
6–10	78.36	0.080	−9.42-166.15	17.59	0.403	−23.68-58.82
≥ 11	368.68	< 0.001	289.32–448.04	66.93	0.025	8.55–125.32
HbA1c (ref: ≤6.9)
Fair (7–7.9)	45.42	0.216	−26.60-177.43	−1.20	0.949	−63.50-59.51
Poor (≥8)	79.41	0.009	20.30–138.53	22.50	0.406	−30.58-75.58
History of co-morbidity (ref: None)
Hypertension	164.89	< 0.001	76.10–252.79	30.13	0.213	−17.25-77.51
Dyslipidaemia	−42.17	0.494	− 163.00-78.66	2.88	0.924	−65.16-61.91
Hypertension+dyslipidaemia	169.07	0.001	68.60–269.55	53.07	0.098	−9.75-115.89
Number of complication (ref: None)
One or two	210.54	< 0.001	134.48–28,660	63.69	0.003	21.70–105.68
Three or more	847.72	< 0.001	739.82–955.63	440.93	< 0.001	274.08–607.85

ISSN: 1472-6963